Cigarette smoking has reached its lowest level ever recorded among US adults – and the youth rate has dropped even further, the federal government reported on Thursday.
About 14 percent of Americans or 34 million people, according to the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Cancer Institute smoked cigarettes in the last 30 days, down 15.5 percent a year 2016. The new rate represents a decline of 67 percent since 1965.
About 10 percent of 18- to 24-year-olds smoked cigarettes in 2017, compared with 13 percent in 2016.
If so, that would be the case If this were a public health success Many young people were not addicted to smoking through electronic cigarettes or vaping.
Overall nicotine consumption reflects this: About 20 percent of US adults used a tobacco product last year over e-cigarettes, chewing tobacco, cigarettes, cigars and waterpipes.
Cigarette smoking is the most common preventable cause of death and disease in the United States and represents the largest health-related problem with tobacco.
About 16 million Americans have a smoking-related illness and about 480,000 die each year. By eliminating smoking in America, about one third of all cancer deaths would be eliminated, according to the National Cancer Institute.
David Ashley, a former FDA official and CDC official, says the new data suggest that "tobacco control efforts are still on track".
Former FDA and CDC official David Ashley, a professor at Georgia State University The School of Public Health will be screened on November 1, 2018 on a youthful doping group run by the Interest Group Truth Initiative is sponsored. On his right is Dr. Milagros "Mila" Váscones-Gatski. She is a drug abuse adviser at Arlington Public Schools and on her right is Cornell University student Jack Waxman, who founded a group at Vaping's school. (Photo: Davon Harris)
But smoking still has a strong impact on disadvantaged and other groups, federal data show. More than 40 percent of adults who reported "severe mental stress" used tobacco. Around 27 percent of the LGBTQ community reported tobacco use.
"The continuing differences in adult smoking prevalence described in this report emphasize the need for further research to accelerate the reduction of tobacco use among all Americans," says Dr. Norman Sharpless, director of the National Cancer Institute.
Vaping was designed to help smokers transition from cancer-causing tobacco, thereby reducing smoking rates. Vapers uses e-cigarettes to inhale nicotine-rich water vapor.
But the practice has also drawn alarming numbers from non-smoking teenagers. 19659006] FDA Commissioner Scott Gottlieb said the government's preliminary data show that teen vaping has reached an "epidemic" level.
He said in September his agency would demand that the major e-cigarette manufacturers prove that they are keeping enough of the hands of children and adolescents.
He threatens to stop selling manufacturers who do not stick to it. An announcement is expected in mid-November.
Ashley, now professed or at Georgia State University's School of Public Health, data show that more than 80 percent of smokers who take e-cigarettes do not use them regularly.
These smokers either reject fumes and return exclusively for smoking or use both traditional cigarettes and e-cigarettes – which drastically reduces benefits, says Ashley.
He says current trends raise "serious concerns".
"Whether steaming will reduce or increase the health of the population from a health point of view, has yet to be determined," he says. "More needs to be done to reduce cigarette addiction and increase the effectiveness of e-cigarettes to help smokers transition completely to greater public health benefits."
If you're interested in online contacts Anyone who has overcome or is currently struggling with health issues mentioned in this story joins USA TODAY's Facebook Support Group "I Survived It", founded in 1945 ,
Read or Share This Article: https://www.usatoday.com/story/news/health/2018/11/08/tobacco-cigarette-smoking-youth-vaping- Epidemic Lung Cancer-CDC-FDA / 1926319002 /